Methylene Blue Absorption: How Much Reaches Your Bloodstream and Brain

How much methylene blue gets into your body depends on two things that most articles blur together: how much crosses the gut wall, and where it goes once it is inside. The best human study puts oral absorption from a water-based solution at about 72%. A second study, which measured whole blood instead of plasma, found far less. Both are correct, and the gap between them explains most of what matters for a daily supplement.

This guide walks through the published pharmacokinetic data in plain terms: the bioavailability studies, how long a dose takes to peak, whether it reaches the brain, how the body clears it, and what changes the numbers. It also covers the other meaning of “methylene blue absorption” that lab scientists search for, which is the dye’s light absorption spectrum. NooBlue sells methylene blue capsules, gummies and drops, so we have a commercial interest in this subject. We have reported the studies as they stand, including where they stop. Written by the NooBlue editorial team.

Methylene Blue Absorption at a Glance

The figures below come from human studies and from the prescribing information for ProvayBlue, a prescription methylene blue injection. Almost all of them were measured at doses far above a supplement serving. Keep that caveat in mind for everything on this page.

Two Meanings of “Methylene Blue Absorption”

Search for methylene blue absorption and most of the top results are about light, not digestion. In chemistry, absorption describes the wavelengths a substance soaks up. Methylene blue absorbs strongly in the red part of the visible spectrum, which is why a solution looks deep blue. The Merck Index figures quoted in the Oregon Medical Laser Center’s spectra database put the peaks at 668 nm and 609 nm. The same page shows a spectrum Scott Prahl recorded from a 10 µM solution in water in a 1 cm quartz cuvette (OMLC methylene blue spectra).

The shape of that spectrum shifts with concentration. Methylene blue molecules stack together in water, first as pairs (dimers). A 2020 analysis in ACS Omega found that groups of four are also present, at low levels, even below about 11 ppm (Fernández-Pérez and Marbán, 2020). That is one reason labs work with dilute samples when they use the absorbance peak to work out how much dye is present.

A third meaning is adsorption, spelled with a “d”, where the dye sticks to the surface of a solid. One 2025 study of modified fly ash notes that methylene blue “is often used as a typical dye to evaluate the performance of adsorbents” (Zhou et al., Molecules, 2025). That is why it turns up so often in water-treatment research.

None of this tells you what happens after you swallow a dose. A spectrometer can confirm what is in a bottle. Only blood samples taken over time show how much crosses the gut wall, and that second question is what the rest of this page answers. If your interest is what is in the bottle, our guide to methylene blue purity covers grades and testing.

How Much Methylene Blue Reaches Your Bloodstream?

Two human studies measured oral absorption directly. Nearly every bioavailability figure quoted online traces back to one of them.

The 72% study: plasma after a water-based oral dose

In a crossover study in Heidelberg, 16 healthy volunteers received a single 50 mg dose into a vein and, after a one-week washout, a single 500 mg dose by mouth as a water-based solution. The researchers measured methylene blue in plasma. The average area under the curve was 7,639 ng/mL·h after the IV dose and 51,171 ng/mL·h after the oral dose. Corrected for the tenfold difference in dose, the absolute bioavailability came out at 72.3%, plus or minus 23.9% (Walter-Sack et al., European Journal of Clinical Pharmacology, 2009).

The spread matters as much as the average. A standard deviation of 23.9 percentage points means individual results ranged widely around 72%. The study also used a dose 100 times larger than one 5 mg capsule. No one has published a bioavailability figure at supplement doses.

The whole-blood study: a much lower number

Nine years earlier, a team in Bern gave seven volunteers 100 mg of methylene blue by vein and by mouth, and measured it in whole blood. Oral exposure was far lower: 9 nmol/min/ml against 137 nmol/min/ml after the injection. The team also tracked urine. Excretion of methylene blue plus its colorless reduced form came to 18% of the dose after oral use and 28% after IV use, a much smaller gap than the blood figures suggest (Peter et al., European Journal of Clinical Pharmacology, 2000).

The authors concluded that differences in where the drug goes in the body are mainly responsible for the gap. In their rat experiments, dosing into the gut gave higher levels in the intestinal wall and liver, and lower levels in blood and brain, than an injection did.

Why the two studies disagree

They were not measuring the same thing. Methylene blue moves in and out of blood cells. According to the injection’s prescribing information, the blood-to-plasma ratio was 5.1 five minutes after the start of a 2 mg/kg infusion and settled at 0.6 after four hours. A whole-blood reading and a plasma reading can therefore tell different stories about the same dose. The Heidelberg team saw this directly: adding chloroquine raised plasma levels but not whole-blood levels. Dose, formulation and assay methods also differed between the two studies.

Our reading of the evidence: a large share of a swallowed dose is absorbed, and much of it goes to the gut wall and liver first. For more on how liquid and capsule forms compare, see our breakdown of methylene blue bioavailability in liquid vs capsules.

How Methylene Blue Crosses the Gut Wall

Methylene blue is a redox molecule. It switches between an oxidized blue form and a reduced, colorless form called leucomethylene blue. The chloride salt sold as methylene blue is stabilized in the blue form, but in the body the two forms sit in equilibrium (Baddeley et al., 2015). Our explainer on what leucomethylene blue is covers the chemistry in more detail.

That switch shapes how the molecule gets into cells. In human red blood cells, the blue form is first reduced outside the cell. The reduced form is then taken up and partly oxidized again, and both forms end up concentrated inside the cell (May et al., American Journal of Physiology: Cell Physiology, 2004). The injection’s label describes the same first step, stating that methylene blue is converted to leucomethylene blue by an NADPH reductase.

A pump that pushes some of it back

Gut cells carry P-glycoprotein, a pump that returns some drugs to the gut. In a Caco-2 cell model of the intestinal lining, methylene blue moved at 2 to 6 × 10^-6 cm/s depending on direction. Blocking P-glycoprotein halved that threefold difference, which marks methylene blue as a partial substrate of the pump (Senarathna et al., PLoS One, 2016). The injection’s label agrees that methylene blue is a P-glycoprotein substrate in lab tests, and says it is not a substrate of two other transporters, BCRP and OCT2.

The Caco-2 authors suggested that drugs which block this pump could raise methylene blue absorption. That is a lab finding rather than a measured human effect, but it is one more reason to check any combination with a pharmacist.

Dissolution: why the form matters

The clearest human evidence that formulation changes absorption comes from a large clinical program run with methylthioninium chloride, the drug name for methylene blue. Researchers looked back at why the higher of two daily doses (228 mg against 138 mg) had unexpectedly shown no effect. They found that the amount of drug released in water or stomach fluid within 60 minutes was an important factor, and that 100 mg capsules had been used to deliver the higher dose. They also found a dose-dependent limit on absorbing the blue form when food was present (Baddeley et al., Journal of Pharmacology and Experimental Therapeutics, 2015).

Those doses are dozens of times larger than a supplement serving, so the lesson for a 5 mg product is general rather than numerical. A form that dissolves quickly and predictably is more likely to give consistent absorption from one day to the next.

When Does Methylene Blue Peak in the Blood?

For a plain oral dose, blood levels peak quickly. The 2016 imaging trial described below scanned volunteers 60 minutes after dosing because an earlier study had found that methylene blue “reached its maximum concentration in whole blood 1 hour after oral methylene blue administration in healthy subjects” (Rodriguez et al., 2016).

Delayed-release forms behave very differently. Methylene blue MMX tablets are built to release the dye in the colon so it can stain the bowel lining during colonoscopy. In healthy volunteers, the median time to peak was 12 hours after 100 mg and 16 hours after 200 mg (Di Stefano et al., Contemporary Clinical Trials, 2018).

No study has published peak timing for 5 mg capsules, 10 mg gummies or small doses of drops. A capsule has to open and dissolve first, so a slightly later peak than a liquid is a reasonable expectation. That is an inference, though, not a measurement. Our guides on how long methylene blue takes to work and the best time of day to take it go further into timing.

Does Methylene Blue Reach the Brain?

Yes, but the route matters. In the Bern study’s rat experiments, methylene blue given into the gut produced lower brain concentrations than the same drug given into a vein. The authors wrote that for effects in the central nervous system, IV dosing “which results in much higher concentrations in brain seems preferable” (Peter et al., 2000).

Oral methylene blue still reaches the human brain in amounts large enough to measure an effect. In a randomized, double-blind, placebo-controlled trial, 26 healthy adults aged 22 to 62 took a single oral dose of 280 mg, about 4 mg/kg. One hour later, functional MRI showed stronger responses in the insular cortex during a sustained-attention task, and in prefrontal, parietal and occipital areas during a short-term memory task. Correct responses during memory retrieval rose by 7% (Rodriguez et al., Radiology, 2016). A 2017 follow-up with the same single 280 mg dose found lower blood flow in a task-related network during a visual-motor task and stronger resting-state connectivity between regions involved in perception and memory (Rodriguez et al., Brain Imaging and Behavior, 2017).

Keep the dose in view. A 280 mg dose is 56 times one NooBlue capsule and 28 times one gummy. There is no brain-imaging data at 5 or 10 mg, so these trials show that oral methylene blue gets into the brain, not what a supplement serving does there. For the mechanism, see how methylene blue works in the mitochondria. For the research on focus and mental energy, see our methylene blue for brain fog guide.

Where It Goes, How It Is Broken Down and How Long It Stays

Distribution

After a 2 mg/kg IV dose, the steady-state volume of distribution averaged 255 L, plus or minus 58. A volume many times larger than the body’s blood volume means most of the drug sits in tissues rather than in circulation. In lab tests, about 94% of the methylene blue in plasma is bound to proteins (ProvayBlue prescribing information).

Metabolism

The liver does most of the work. The label describes methylene blue as “extensively metabolized in the liver.” In lab studies, the enzymes CYP1A2, CYP2C19 and CYP2D6 can process it, but the main pathway appears to be conjugation by UGT enzymes, including UGT1A4 and UGT1A9. Removing one methyl group produces azure B, which forms in humans at a parent-to-metabolite exposure ratio above 6 to 1.

Older articles, including an earlier version of this one, called the metabolites inert. That was wrong. Azure B blocks the enzyme MAO-A with an IC50 of 11 nM in lab tests, about six times more potently than methylene blue itself at 70 nM (Petzer et al., Toxicology and Applied Pharmacology, 2012). That finding matters for the interaction warning below. Our page on methylene blue and the liver has more on this.

Half-life

The injection’s label gives a half-life of about 24 hours in humans. Individual studies vary with method and formulation. The Bern team estimated a terminal half-life of 5.25 hours in whole blood after an IV dose, and the delayed-release tablet study reported 9 to 22 hours after 100 mg and 6 to 26 hours after 200 mg. On the label figure, a daily dose has not fully cleared by the time the next one arrives. Our methylene blue half-life guide works through what that means for a routine.

Why Your Urine Turns Blue-Green

The kidneys clear a large share of each dose. The label states that about 40% of methylene blue is excreted into the urine unchanged, and that the dye “passes freely into the urine.” In the delayed-release tablet study, cumulative urinary excretion reached about 28% of a 100 mg dose and about 39% of a 200 mg dose within 60 hours. The label also warns that methylene blue can interfere with urine tests that rely on a blue indicator, such as the dipstick test for leukocyte esterase, and that it can tint the skin and body fluids blue.

You may read that blue urine proves a product was absorbed, and that clear urine means a product is fake. Neither claim holds up. Part of each dose leaves as the colorless leuco form, which the Bern team measured alongside the blue form, and a 5 mg serving is a small amount of dye spread through a day’s urine. Color is a rough sign at best. Our guide to methylene blue urine color covers what to expect.

What Changes How Much You Absorb

Other medicines

In the Heidelberg study, adding 750 mg of chloroquine to a 500 mg oral dose raised average plasma exposure from 51,171 to 76,897 ng/mL·h, while whole-blood levels did not rise. The Caco-2 work above suggests that drugs which block P-glycoprotein could have a similar effect. Higher exposure is not a goal in itself, and it is one reason to speak to a doctor or pharmacist before combining methylene blue with any prescription medicine. Our guide to what not to take with methylene blue has the full list.

Food

No study has measured food effects at supplement doses. At clinical doses, the Baddeley analysis found that food limited absorption of the blue form in a dose-dependent way. Our capsule label says to take one capsule daily with food, and at 5 mg that trade-off has not been studied. The practical rule is consistency: take it the same way each day, so any food effect stays constant.

Kidney and liver function

Because the kidneys and liver clear methylene blue, their function changes exposure. After a single 1 mg/kg IV dose, total exposure rose by 52%, 116% and 192% in people with mild, moderate and severe kidney impairment. The label also advises monitoring people with any liver impairment for longer, because clearance is delayed. If you have kidney or liver problems, talk to your doctor before taking methylene blue in any form.

Individual variation

The spread of plus or minus 23.9 points in the 72% study shows that people absorb different amounts even under identical study conditions. Genes and gut transit time probably play a part. No study has measured how much each one contributes for methylene blue.

Capsules, Gummies or Drops: What the Absorption Data Means for Each

None of the three NooBlue formats has its own published pharmacokinetic study, and we are not aware of one for any other brand’s supplement either. Here is what each format contains and how it relates to the research above. Prices as of Sep 2026.

If you want a fixed dose with nothing to measure, the capsules give 5 mg each. If you want the format closest to the solution used in the bioavailability study, the drops are it, and they let you adjust in 0.5 mg steps. The gummies pair 10 mg with vitamin C in a chewable form. The gummy product page is clear that its ingredient report “does not measure the finished formula’s redox balance or absorption,” and this article holds to the same line. Our guide to taking methylene blue drops covers measuring and mixing, and the gummies vs capsules comparison sets out the trade-offs between the two solid forms.

On testing: Contract Testing Laboratories of America (CTLA) analyzed the methylene blue ingredient, lot 2025022801, in report 135621, for identity by HPLC and for four heavy metals. That report covers the raw ingredient, not each finished batch, and it does not state a purity percentage. You can read it on our quality page, and our certificate of analysis guide explains how to read a report like it.

Safety: Who Should Not Take Methylene Blue

Absorption data matters most for safety, because anything that raises exposure raises risk. These warnings apply to every format and every dose.

• Serotonergic medicines. Methylene blue is a potent reversible inhibitor of MAO-A (Ramsay et al., British Journal of Pharmacology, 2007). A systematic review found 26 patients who developed an acute confusional state after a methylene blue infusion. Of those, 24 were taking a serotonin reuptake inhibitor and one was taking clomipramine, and serotonin syndrome was a possible diagnosis in all 25 (Ng and Cameron, Psychosomatics, 2010). Do not combine methylene blue with SSRIs, SNRIs, MAOIs or other serotonergic medicines. The injection’s label adds that opioids and dextromethorphan may increase the risk.
• G6PD deficiency. The injection is contraindicated in people with G6PD deficiency because of the risk of hemolytic anemia. If you do not know your G6PD status, ask your doctor about testing before you start.
• Pregnancy and breastfeeding. The label states that methylene blue may cause fetal harm, and advises stopping breastfeeding during treatment and for up to 8 days afterwards. Do not take it while pregnant or breastfeeding.
• Kidney or liver impairment. Exposure rises when clearance falls, as shown above. Talk to your doctor first.

For more detail, see our guides to methylene blue and serotonin syndrome, methylene blue and G6PD deficiency, who should not take methylene blue and methylene blue side effects.

The Bottom Line on Methylene Blue Absorption

A water-based oral dose of methylene blue is well absorbed, with an average plasma bioavailability of 72.3% in the only absolute bioavailability study. Much of it goes to the gut wall and liver first. A plain oral dose peaks in about an hour, and at 280 mg it reaches the brain in amounts that change brain activity on a scan. It clears slowly, with a half-life of about a day.

All of those numbers come from doses far larger than a supplement serving. At 5 or 10 mg, the things you control are taking a consistent form in a consistent way and avoiding the interactions above. For daily amounts, start with our guide to how many mg of methylene blue per day. If you are comparing brands, our best methylene blue supplements roundup sets out the options, and everything we make is in the NooBlue shop.

Frequently Asked Questions

How quickly does methylene blue kick in?

Blood levels from a plain oral dose peak around one hour after you take it, based on the whole-blood data cited by the 2016 imaging trial, which scanned volunteers at that point. Whether you notice anything at a 5 mg or 10 mg serving is a separate question that no trial has answered. A capsule has to dissolve first, so it may run a little behind a liquid.

How long does it take methylene blue to enter the bloodstream?

Absorption starts once the dose dissolves in the gut, and blood levels of a plain oral dose peak at about one hour. Delayed-release tablets designed for the colon are the exception: they peaked after a median of 12 to 16 hours in healthy volunteers. No study has measured the full time course for 5 mg capsules, gummies or drops.

What should you not mix with methylene blue?

Do not mix it with serotonergic medicines, including SSRIs, SNRIs and MAOIs, because methylene blue strongly inhibits MAO-A and the combination has been linked to serotonin syndrome. The injection’s label adds opioids and dextromethorphan. Chloroquine raised plasma methylene blue levels in a human study, and drugs that block P-glycoprotein may do the same. Ask a pharmacist before combining it with any medicine, and see our list of what not to take with methylene blue.

How many drops of methylene blue should I take?

With a 1% solution such as NooBlue drops, each drop carries 0.5 mg, so 10 drops make one 5 mg serving and a full dropper holds 10 mg. Follow the label on the bottle you buy, because concentrations differ between brands. Our methylene blue dosage guide covers daily amounts, and nobody taking serotonergic medicines should take any.

Does methylene blue cross the blood-brain barrier?

Yes. Human imaging trials found changes in brain activity one hour after a single 280 mg oral dose, and rat work found that brain levels after gut dosing were lower than after an injection. No study has measured brain levels at supplement doses.

Does taking methylene blue with food reduce absorption?

At clinical doses it can. An analysis of a methylthioninium chloride program found a dose-dependent limit on absorbing the blue form when food was present. No one has tested this at 5 or 10 mg. Our capsule label says to take one capsule daily with food, and the more useful habit is to take it the same way every day.

Why is my urine blue after taking methylene blue?

The kidneys excrete a large share of each dose unchanged, about 40% according to the injection’s label. The dye passes freely into urine and can tint it blue or blue-green. It can also interfere with urine dipstick tests that use a blue indicator, so tell whoever is testing you. Color is not a reliable test of product quality, since part of the dose leaves in the colorless form.

Does the 668 nm absorbance peak tell you anything about how much you absorb?

No. The absorbance peaks near 668 nm and 609 nm are optical properties. Labs use them to measure methylene blue in a sample, and they explain why the solution looks blue. Gut absorption can only be answered by measuring blood over time, which is where the 72.3% figure comes from.

Does a 10 mg dose absorb the same percentage as a 5 mg dose?

Nobody knows. The only absolute bioavailability study used 500 mg, and no human study compares 5 mg with 10 mg. The Baddeley analysis found dose-dependent effects with food at clinical doses, so the absorbed fraction need not stay flat as the dose changes. Stay within the label either way.

Sources

1. Walter-Sack I, Rengelshausen J, Oberwittler H, et al. High absolute bioavailability of methylene blue given as an aqueous oral formulation. European Journal of Clinical Pharmacology. 2009;65(2):179-189. PubMed 18810398
2. Peter C, Hongwan D, Küpfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. European Journal of Clinical Pharmacology. 2000;56(3):247-250. PubMed 10952480
3. Senarathna SM, Page-Sharp M, Crowe A. The interactions of P-glycoprotein with antimalarial drugs, including substrate affinity, inhibition and regulation. PLoS One. 2016;11(4):e0152677. PubMed 27045516
4. Baddeley TC, McCaffrey J, Storey JM, et al. Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer’s disease. Journal of Pharmacology and Experimental Therapeutics. 2015;352(1):110-118. PubMed 25320049
5. May JM, Qu ZC, Cobb CE. Reduction and uptake of methylene blue by human erythrocytes. American Journal of Physiology: Cell Physiology. 2004;286(6):C1390-C1398. PubMed 14973146
6. Di Stefano AFD, Radicioni MM, Vaccani A, et al. Methylene blue MMX tablets for chromoendoscopy: bioavailability, colon staining and safety in healthy volunteers undergoing a full colonoscopy. Contemporary Clinical Trials. 2018;71:96-102. PubMed 29864547
7. Rodriguez P, Zhou W, Barrett DW, et al. Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. 2016;281(2):516-526. PubMed 27351678
8. Rodriguez P, Singh AP, Malloy KE, et al. Methylene blue modulates functional connectivity in the human brain. Brain Imaging and Behavior. 2017;11(3):640-648. PubMed 26961091
9. Petzer A, Harvey BH, Wegener G, Petzer JP. Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase. Toxicology and Applied Pharmacology. 2012;258(3):403-409. PubMed 22197611
10. Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology. 2007;152(6):946-951. PubMed 17721552
11. Ng BK, Cameron AJ. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics. 2010;51(3):194-200. PubMed 20484716
12. ProvayBlue (methylene blue) injection, prescribing information, revised 2/2024. DailyMed
13. Prahl S. Methylene Blue spectra. Oregon Medical Laser Center. omlc.org
14. Fernández-Pérez A, Marbán G. Visible light spectroscopic analysis of methylene blue in water: what comes after dimer? ACS Omega. 2020. PubMed 33251415
15. Zhou J, Li M, Tao Y, Zha L. Study on the adsorption characteristics of methylene blue by magnesium-modified fly ash. Molecules. 2025;30(5):992. mdpi.com
16. NooBlue product pages and quality page (label amounts and the CTLA ingredient report), read Sep 2026. nooblue.com/quality